Cargando…

Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26.COV2.S vaccination

Detalles Bibliográficos
Autores principales:	Kulkarni, Prathit A., Prasad, Vinay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Higher Education Press 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482953/ https://www.ncbi.nlm.nih.gov/pubmed/34595694 http://dx.doi.org/10.1007/s11684-021-0895-9

Ejemplares similares

Most cases of Thrombosis and Thrombocytopenia Syndrome (TTS) post ChAdOx-1 nCov-19 are Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT)
por: Makris, Michael, et al.
Publicado: (2021)

Ad26.cov2-s: Thrombosis with thrombocytopenia syndrome: case report
Publicado: (2022)

Ad26.cov2-s: Thrombosis with thrombocytopenia syndrome: 3 case reports
Publicado: (2021)

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination
por: Muir, Kate-Lynn, et al.
Publicado: (2021)

Ad26.CoV2-S/elasomeran: Thrombosis with thrombocytopenia syndrome: 6 case reports
Publicado: (2022)

A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson & Johnson)()
por: Castan, Maxime, et al.
Publicado: (2022)

Thrombosis with Thrombocytopenia Syndrome After Administration of AZD1222 or Ad26.COV2.S Vaccine for COVID-19: A Systematic Review
por: Waqar, Usama, et al.
Publicado: (2021)

Widespread cutaneous reaction to the Johnson & Johnson Ad26.COV2.S vaccine
por: Sowell, Josiah, et al.
Publicado: (2021)

Early Outcomes of Bivalirudin Therapy for Thrombotic Thrombocytopenia and Cerebral Venous Sinus Thrombosis After Ad26.COV2.S Vaccination
por: Clark, Richard Todd, et al.
Publicado: (2021)

Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccination
por: Buoninfante, Alessandra, et al.
Publicado: (2022)

Reply to “Widespread Cutaneous Reaction to the Johnson & Johnson Ad26.Cov2.S Vaccine”
por: Malachowski, Stephen J., et al.
Publicado: (2022)

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination — Response from the Manufacturer
por: Sadoff, Jerald, et al.
Publicado: (2021)

Ad26.COV2-S: Cerebral Venous Sinus Thrombosis with Thrombocytopenia: 14 case reports
Publicado: (2021)

Ad26.COV2-S: Thrombotic thrombocytopenia and cerebral venous sinus thrombosis: case report
Publicado: (2021)

Deep Venous Thrombosis after Ad26.COV2.S Vaccination in Adult Male
por: Hussain, Habiba, et al.
Publicado: (2021)

Ad26.COV2-S: Thrombotic thrombocytopenia: case report
Publicado: (2021)

Ad26.cov2-s: Thrombotic thrombocytopenia: case report
Publicado: (2022)

Ad26.COV2-S: Transient thrombocytopenia: case report
Publicado: (2022)

Ad26.COV2-S: Thrombotic thrombocytopenia: case report
Publicado: (2021)

Cerebral venous thrombosis without thrombocytopenia after a single dose of COVID-19 (Ad26.COV2.S) vaccine injection: a case report
por: Di Pietro, Martina, et al.
Publicado: (2022)

Thrombocytopenia after Ad.26.COV2.S COVID-19 vaccine: Reports to the vaccine adverse event reporting system
por: Woo, Emily Jane, et al.
Publicado: (2022)

Understanding vaccine-induced immune thrombocytopenia and thrombosis
por: Hunt, B.
Publicado: (2021)

Fatal intracerebral haemorrhage associated with thrombosis with thrombocytopenia syndrome after ChAdOx1-S vaccine
por: Gómez-Roldós, Ana, et al.
Publicado: (2022)

SARS-CoV-2 vaccines–induced thrombotic thrombocytopenia: should we consider immuno-hypersensitivity?
por: Reuben, Rine Christopher, et al.
Publicado: (2021)

Ad26.cov2-s/AZD-1222: Cerebral venous sinus thrombosis and thrombotic thrombocytopenia: 3 case reports
Publicado: (2022)

Inflammatory myositis after ChAdOx1 vaccination
por: Maramattom, Boby Varkey, et al.
Publicado: (2021)

Cerebral venous sinus thrombosis after vaccination: the UK experience
por: Lee, Eun-Ju, et al.
Publicado: (2021)

Response to Berry et al’s “Cutaneous small-vessel vasculitis following single-dose Janssen Ad26.COV2.S vaccination”
por: Matthews, Natalie H., et al.
Publicado: (2022)

Guillain-Barré Syndrome After Ad26.COV2.S Vaccination
por: Thant, Hein Linn, et al.
Publicado: (2022)

Multisystem Inflammatory Syndrome after Ad26.COV2.S vaccination
por: Bova, Carlo, et al.
Publicado: (2022)

Impact of vaccine pause due to Thrombosis with thrombocytopenia syndrome (TTS) following vaccination with the Ad26.COV2.S vaccine manufactured by Janssen/Johnson & Johnson on vaccine hesitancy and acceptance among the unvaccinated population
por: Salmon, Daniel A., et al.
Publicado: (2022)

Lessons from vaccine-induced immune thrombotic thrombocytopenia
por: Kelton, John Greenhow, et al.
Publicado: (2021)

Ad26.COV2-S: Immune thrombotic thrombocytopenia: case report
Publicado: (2022)

Ad26.cov2-s: Immune thrombotic thrombocytopenia: case report
Publicado: (2022)

Ad26.cov2-s: Immune-thrombotic thrombocytopenia: case report
Publicado: (2022)

Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with ChAdOx1 nCov-19 vaccine
por: Scavone, Mariangela, et al.
Publicado: (2021)

Severe Thrombocytopenia Two Weeks Following Immunization with the Janssen Ad26.CoV2.S Vaccine
por: Antonios, Bana, et al.
Publicado: (2022)

Ad26.COV2.S Vaccine-Induced Thrombocytopenia Leading to Dural Sinus Thrombosis and Intracranial Hemorrhage Requiring Hemicraniectomy: A Case Report and Systematic Review
por: Daly, Samuel R, et al.
Publicado: (2022)

Thrombosis and thrombocytopenia after HPV vaccination
por: Johansen, Silje, et al.
Publicado: (2022)

Cerebral venous sinus thrombosis after ChAdOx1 vaccination: the first case of definite thrombosis with thrombocytopenia syndrome from India
por: Maramattom, Boby Varkey, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6ba9s7e0b9c8tv25stsquc5ee0